Further, increased cerebrospinal fluid levels of S100B have been also reported in Parkinson’s disease (Sathe et al., 2012), AD (Edwards and Robinson, 2006), and schizophrenia (Schmitt et al., 2005), implying roles for S100B in the pathogenesis of neurodegenerative diseases. This evidence concerns the gene S100B and neurodegenerative disease.